Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02926690 |
| Title | Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | OncoTherapy Science, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Norwalk Hospital | COMPLETED | Norwalk | Connecticut | 06856 | United States | Details |
| Weill Cornell Medicine | NewYork-Presbyterian | COMPLETED | New York | New York | 10065 | United States | Details |
| Memorial Sloan Kettering Cancer Center | RECRUITING | New York | New York | 11065 | United States | Details |
| MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |